Rosa Lerose

1.9k total citations · 1 hit paper
34 papers, 1.1k citations indexed

About

Rosa Lerose is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Rosa Lerose has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in Rosa Lerose's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (6 papers) and Cancer therapeutics and mechanisms (4 papers). Rosa Lerose is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (6 papers) and Cancer therapeutics and mechanisms (4 papers). Rosa Lerose collaborates with scholars based in Italy, United States and Iran. Rosa Lerose's co-authors include Alfredo Tartarone, Giuseppina Gallucci, Michele Aieta, A. Capobianco, A.V. Lalinga, Arturo Leone, Maria Caterina Turco, Maria Pascale, Silvia Franceschelli and Alessandra Rosati and has published in prestigious journals such as Blood, Gastroenterology and FEBS Letters.

In The Last Decade

Rosa Lerose

32 papers receiving 1.1k citations

Hit Papers

Cardiovascular risk of smoking and benefits of smoking ce... 2020 2026 2022 2024 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosa Lerose Italy 17 406 360 227 114 109 34 1.1k
Abraham J. Wilhelm Netherlands 24 311 0.8× 354 1.0× 161 0.7× 59 0.5× 87 0.8× 61 1.7k
Ching‐Liang Ho Taiwan 21 438 1.1× 459 1.3× 249 1.1× 70 0.6× 186 1.7× 114 1.5k
Kiran Sharma India 20 379 0.9× 305 0.8× 201 0.9× 63 0.6× 139 1.3× 61 1.3k
Andrzej Deptała Poland 22 673 1.7× 519 1.4× 338 1.5× 64 0.6× 152 1.4× 105 1.7k
Saketh R. Guntupalli United States 21 388 1.0× 373 1.0× 205 0.9× 144 1.3× 117 1.1× 87 1.9k
Annamaria Catino Italy 22 329 0.8× 476 1.3× 453 2.0× 141 1.2× 76 0.7× 114 1.5k
Javier Gómez United States 18 270 0.7× 361 1.0× 373 1.6× 180 1.6× 86 0.8× 51 1.0k
Prabhu Rajagopalan United States 17 365 0.9× 360 1.0× 252 1.1× 79 0.7× 138 1.3× 51 1.1k
Fikret Arpacı Türkiye 19 267 0.7× 456 1.3× 154 0.7× 37 0.3× 82 0.8× 74 1.1k
Natasha Aziz United States 19 791 1.9× 239 0.7× 409 1.8× 77 0.7× 97 0.9× 37 1.7k

Countries citing papers authored by Rosa Lerose

Since Specialization
Citations

This map shows the geographic impact of Rosa Lerose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Lerose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Lerose more than expected).

Fields of papers citing papers by Rosa Lerose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Lerose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Lerose. The network helps show where Rosa Lerose may publish in the future.

Co-authorship network of co-authors of Rosa Lerose

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Lerose. A scholar is included among the top collaborators of Rosa Lerose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Lerose. Rosa Lerose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Masci, Domiziana, Antonio Coluccia, Maurice Santelli, et al.. (2025). Microwave-assisted synthesis of tubulin assembly inhibitors as anticancer agents by aryl ring reversal and conjunctive approach. RSC Medicinal Chemistry. 16(10). 4845–4858. 1 indexed citations
2.
Crispo, Fabiana, et al.. (2025). The Oncoprotein Mucin 1 in Pancreatic Cancer Onset and Progression: Potential Clinical Implications. Biomolecules. 15(2). 275–275. 3 indexed citations
3.
Tartarone, Alfredo, et al.. (2023). Current Treatment Approaches for Thymic Epithelial Tumors. Life. 13(5). 1170–1170. 8 indexed citations
5.
Tartarone, Alfredo, et al.. (2022). Management of oligoprogression in non-small cell lung cancer patients. Medical Oncology. 39(5). 56–56. 1 indexed citations
6.
Gallucci, Giuseppina, Alfredo Tartarone, Rosa Lerose, A.V. Lalinga, & A. Capobianco. (2020). Cardiovascular risk of smoking and benefits of smoking cessation. Journal of Thoracic Disease. 12(7). 3866–3876. 235 indexed citations breakdown →
7.
Tartarone, Alfredo, Rosa Lerose, & Michele Aieta. (2020). Focus on lung cancer screening. Journal of Thoracic Disease. 12(7). 3815–3820. 11 indexed citations
8.
Tartarone, Alfredo & Rosa Lerose. (2020). COVID-19 and cancer care: what do international guidelines say?. Medical Oncology. 37(9). 80–80. 24 indexed citations
9.
Tartarone, Alfredo, Rosa Lerose, & Michele Aieta. (2018). Is there a role for immunotherapy in malignant pleural mesothelioma?. Medical Oncology. 35(7). 98–98. 3 indexed citations
10.
Tartarone, Alfredo, Pasqualina Giordano, Rosa Lerose, et al.. (2017). Progress and challenges in the treatment of small cell lung cancer. Medical Oncology. 34(6). 110–110. 25 indexed citations
11.
Tartarone, Alfredo, et al.. (2017). Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancer. Journal of Thoracic Disease. 9(S13). S1359–S1363. 2 indexed citations
12.
Tartarone, Alfredo, Rosa Lerose, & Michele Aieta. (2016). Somatostatin Analog Therapy in Small Cell Lung Cancer. Seminars in Nuclear Medicine. 46(3). 239–242. 10 indexed citations
13.
Tartarone, Alfredo, et al.. (2016). Possible applications of circulating tumor cells in patients with non small cell lung cancer. Lung Cancer. 107. 59–64. 17 indexed citations
14.
Musto, Pellegrino, et al.. (2016). Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patients. Biologics. 10. 1–1. 19 indexed citations
15.
Tartarone, Alfredo, Rosa Lerose, Giuseppina Gallucci, Raffaele Ardito, & Michele Aieta. (2011). Evaluation of molecular prognostic and predictive factors: an important step towards personalised treatment in non small cell lung cancer. Medical Oncology. 29(3). 1599–1605. 3 indexed citations
16.
Lerose, Rosa, et al.. (2011). Off-label use of anti-cancer drugs between clinical practice and research: the Italian experience. European Journal of Clinical Pharmacology. 68(5). 505–512. 19 indexed citations
17.
Guariglia, Roberto, Maria Carmen Martorelli, Oreste Villani, et al.. (2010). Positive effects on hematopoiesis in patients with myelodysplastic syndrome receiving deferasirox as oral iron chelation therapy: A brief review. Leukemia Research. 35(5). 566–570. 50 indexed citations
18.
Tartarone, Alfredo & Rosa Lerose. (2010). Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: What Do We Know?. Therapeutic Drug Monitoring. 32(6). 669–672. 12 indexed citations
19.
Rosati, Alessandra, Massimo Ammirante, Antonio Gentilella, et al.. (2007). Apoptosis inhibition in cancer cells: A novel molecular pathway that involves BAG3 protein. The International Journal of Biochemistry & Cell Biology. 39(7-8). 1337–1342. 111 indexed citations
20.
Lerose, Rosa, et al.. (2003). Regulation by heavy metals and temperature of the human BAG‐3 gene, a modulator of Hsp70 activity. FEBS Letters. 541(1-3). 11–15. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026